These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6841787)
21. Loco-regional primary and recurrent melanoma: III. Update of natural history and non-systemic treatments (1980-1987). Lee YT Cancer Treat Rev; 1988 Jun; 15(2):135-62. PubMed ID: 3042128 [No Abstract] [Full Text] [Related]
22. Melanoma and other skin neoplasms. Curr Opin Oncol; 1992 Apr; 4(2):410-20. PubMed ID: 1591314 [No Abstract] [Full Text] [Related]
24. [Item no 149: epithelial and melanoma skin tumors: melanoma]. Ann Dermatol Venereol; 2005 Oct; 132(10 Suppl):7S140-7S146. PubMed ID: 16419536 [No Abstract] [Full Text] [Related]
25. Melanoma in 2011. Wiseman MC J Cutan Med Surg; 2011; 15 Suppl 1():S371-3. PubMed ID: 22469203 [No Abstract] [Full Text] [Related]
26. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma]. Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461 [No Abstract] [Full Text] [Related]
27. [Malignant melanoma. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V]. Kaufmann R; Tilgen W; Garbe C Hautarzt; 1998 Oct; 48 Suppl 1():S30-8. PubMed ID: 9866046 [No Abstract] [Full Text] [Related]
28. New trends in the treatment of malignant melanoma. Veronesi U; Bajetta E; Cascinelli N; Clemente C; Rilke F Int Adv Surg Oncol; 1978; 1():113-56. PubMed ID: 399762 [No Abstract] [Full Text] [Related]
33. [Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie]. Guillot B; Charles J; Jeudy G; Cupissol D; Dupuy A; Dutriaux C; Gangloff D; Magne N; Mirabel X; M'Sadek A; Pracht M; Sichel C; Do Outeiro G Ann Dermatol Venereol; 2018; 145(6-7):413-422. PubMed ID: 29703640 [No Abstract] [Full Text] [Related]
34. [Establishment of a 2-stage prognostic classification of primary malignant melanoma derived from a multidimensional analysis and from an agreement study]. Chastang C; Césarini JP; Beltzer-Garelli H; Palangié A; Jacquillat C; Puissant A; Banzet P Rev Epidemiol Sante Publique; 1984; 32(3-4):243-8. PubMed ID: 6395231 [TBL] [Abstract][Full Text] [Related]
36. Nowadays a histological sub-typing of thin melanoma is demanded for a proper patient management. Piscioli F; Pusiol T; Roncati L J Plast Reconstr Aesthet Surg; 2016 Nov; 69(11):1563-1564. PubMed ID: 27639421 [No Abstract] [Full Text] [Related]
37. Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial. Thomas JM J Clin Oncol; 2005 Dec; 23(36):9443-4. PubMed ID: 16361650 [No Abstract] [Full Text] [Related]
38. Melanoma--introduction. McBride CM World J Surg; 1979 Jul; 3(3):251-3. PubMed ID: 473778 [No Abstract] [Full Text] [Related]
39. [The prognosis of patients with level V melanomas of the extremities]. Krüger I; Ghussen F; Groth W Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539 [TBL] [Abstract][Full Text] [Related]